{"title":"A contextualized reinforcer pathology approach to addiction","authors":"Samuel F. Acuff, James MacKillop, James G. Murphy","doi":"10.1038/s44159-023-00167-y","DOIUrl":null,"url":null,"abstract":"Behavioural economic accounts of addiction conceptualize harmful drug use as an operant reinforcer pathology, emphasizing that a drug is consumed because of overvaluation of smaller immediate rewards relative to larger delayed rewards (delay discounting) and high drug reinforcing value (drug demand). These motivational processes are within-individual determinants of behaviour. A third element of learning theory posits that harmful drug use depends on the relative constraints on access to other available activities and commodities in the choice context (alternative reinforcers), reflecting the substantial influence of environmental factors. In this Perspective, we integrate alternative reinforcers into the contemporary behavioural economic account of harmful drug use — the contextualized reinforcer pathology model — and review empirical literature across the translational spectrum in support of this model. Furthermore, we consider how increases in drug-related mortality and health disparities in addiction can be understood and potentially ameliorated via a contextualized reinforcer pathology model in which lack of alternative reinforcement is a major risk factor for addiction. Behavioural economic accounts of addiction suggest that drug consumption arises from overvaluation of small, immediate rewards and drug-specific reinforcement. In this Perspective, Acuff et al. propose an extension to this reinforcer pathology model that highlights the critical role of alternative reinforcers in addiction motivation.","PeriodicalId":74249,"journal":{"name":"Nature reviews psychology","volume":"2 5","pages":"309-323"},"PeriodicalIF":16.8000,"publicationDate":"2023-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028332/pdf/","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature reviews psychology","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44159-023-00167-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 5
Abstract
Behavioural economic accounts of addiction conceptualize harmful drug use as an operant reinforcer pathology, emphasizing that a drug is consumed because of overvaluation of smaller immediate rewards relative to larger delayed rewards (delay discounting) and high drug reinforcing value (drug demand). These motivational processes are within-individual determinants of behaviour. A third element of learning theory posits that harmful drug use depends on the relative constraints on access to other available activities and commodities in the choice context (alternative reinforcers), reflecting the substantial influence of environmental factors. In this Perspective, we integrate alternative reinforcers into the contemporary behavioural economic account of harmful drug use — the contextualized reinforcer pathology model — and review empirical literature across the translational spectrum in support of this model. Furthermore, we consider how increases in drug-related mortality and health disparities in addiction can be understood and potentially ameliorated via a contextualized reinforcer pathology model in which lack of alternative reinforcement is a major risk factor for addiction. Behavioural economic accounts of addiction suggest that drug consumption arises from overvaluation of small, immediate rewards and drug-specific reinforcement. In this Perspective, Acuff et al. propose an extension to this reinforcer pathology model that highlights the critical role of alternative reinforcers in addiction motivation.